Form D · Biotechnology

Kyttaro Ltd

London, X0 · CIK 0001939863

Offering snapshot reported Dec 22, 2022 · SEC filing

Reported sold
$276K
Offering amount: $276K
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 31, 2021
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 22, 2022Initial$275,966No comparison6SEC filing
Dec 22, 2022Initial$2,089,709No comparison27SEC filing
Dec 22, 2022Initial$2,868,477No comparison27SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-468424
SHARES ARE DENOMINATED IN BRITISH POUND STERLING (GBP). ALL OFFERING AND SALES AMOUNTS IN ITEM 13 ARE BASED ON THE GBP TO US DOLLAR (USD) CONVERSION RATE OF 1 GBP = 1.3798 USD, AS OF 03/31/2021.

Source: Form D, filed Dec 22, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Chas Bountra Director
Arkadiy Chapko Executive
Douglas Eby Director, Executive
William Stovin Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
C/O Hillier Hopkins Llp 45 Pall Mall
London, X0, SW1Y 5JG